Where to Buy CircO2: Official Store Guide to Authentic Nitric Oxide Lozenges and Counterfeit Packaging Defense

Nitric oxide (NO) is universally recognized in cardiovascular medicine as the master signaling molecule of the human vascular endothelium. Awarded the Nobel Prize in Physiology or Medicine in 1998, the discovery of endothelial nitric oxide signaling unraveled the foundational mechanism of endothelium-dependent vasodilation - the biochemical process by which smooth muscle cells surrounding arterial walls relax, expanding lumen diameter, lowering systemic peripheral vascular resistance, and optimizing tissue microperfusion.

However, human physiology suffers a relentless, age-dependent collapse in endogenous nitric oxide production. By age 40, the enzymatic activity of endothelial nitric oxide synthase (eNOS) declines by approximately 50%; by age 60, biological eNOS activity plummets by more than 75% to 85%.

This progressive eNOS uncoupling and endothelial senescence triggers chronic arterial stiffness, microvascular hypoperfusion, cold extremities, cognitive sluggishness, and persistent elevations in systolic blood pressure.

To bypass this age-related eNOS enzymatic breakdown, CircO2 - formulated by Advanced Bionutritionals - was engineered to exploit the alternative enterosalivary nitrate-nitrite-nitric oxide pathway.

Delivered as an advanced, orally dissolving sublingual lozenge, CircO2 combines standardized inorganic sodium nitrite, L-citrulline, beetroot extract, Vitamin C (ascorbic acid), and Vitamin B12 (methylcobalamin). When dissolved in the oral cavity, ascorbic acid donates hydrogen ions to nitrite, generating authentic, active nitric oxide gas directly across the sublingual mucosa into arterial circulation within seconds.

Yet, because CircO2's therapeutic mechanism relies on a delicate, moisture-sensitive chemical reaction, authentic product integrity is exceptionally vulnerable to unauthorized supply chains. Atmospheric humidity and temperature fluctuations degrade unprotected nitrite compounds into inactive nitrate salts.

Furthermore, the extraordinary market demand for CircO2 has spawned an illicit trade of counterfeit lozenges sold on third-party digital platforms like Amazon, eBay, and Walmart Marketplace. These fake products consist of compressed sugar chalk, lacking active nitrite or the nitrogen-flushed blister packaging necessary to maintain clinical viability.

Procuring CircO2 directly from the official manufacturer portal is an indispensable clinical prerequisite. This procurement guide provides a deep pharmacological analysis of the enterosalivary NO pathway, examines the chemical degradation risks of improper storage, establishes a forensic authentication checklist, and details the authorized direct procurement architecture.

The Molecular Pharmacology and Active Architecture of CircO2

The human cardiovascular system utilizes two distinct pathways to generate nitric oxide: the L-arginine-eNOS pathway and the enterosalivary nitrate-nitrite-NO pathway. Understanding why CircO2 utilizes the latter is fundamental to appreciating its clinical superiority for aging adults.

1. The Breakdown of the Classic L-Arginine-eNOS Pathway

In youth, endothelial cells utilize eNOS to convert the amino acid L-arginine into nitric oxide and L-citrulline in the presence of essential co-factors, particularly tetrahydrobiopterin (BH4).

With aging, chronic oxidative stress oxidizes BH4 into inactive dihydrobiopterin (BH2). Deprived of BH4, the eNOS enzyme "uncouples." Instead of generating protective nitric oxide, uncoupled eNOS transfers electrons to molecular oxygen, generating superoxide radicals (superoxide radicals (O2•-)).

Superoxide instantly scavenges any remaining nitric oxide, forming peroxynitrite (peroxynitrite (ONOO-)), a potent cytotoxin that damages endothelial membranes, oxidizes LDL particles, and promotes vascular calcification. Consequently, giving high-dose L-arginine supplements to older adults with uncoupled eNOS often fails to increase nitric oxide and can actually exacerbate oxidative stress.

2. The Enterosalivary Nitrate-Nitrite-Nitric Oxide Alternative Pathway

CircO2 completely bypasses uncoupled eNOS by providing direct substrate for the enterosalivary pathway:

• Sodium Nitrite & Ascorbic Acid Reaction: When the CircO2 lozenge dissolves on the tongue, ascorbic acid creates an acidic microenvironment, reducing nitrite (NO2-) into free nitric oxide gas (NO). This gas diffuses immediately across the thin sublingual epithelium directly into the lingual veins, entering systemic circulation without hepatic degradation.
• Microbial Reductase Synergy: Dietary nitrates from standardized beetroot extract interact with anaerobic nitrate-reducing bacteria (Veillonella, Actinomyces, Rothia) residing in the crypts of the posterior tongue, converting nitrate into bioavailable nitrite for sustained secondary systemic release.
• L-Citrulline Recycling: L-citrulline is absorbed enterically and converted by the kidneys via argininosuccinate synthase and argininosuccinate lyase into endogenous L-arginine, providing clean, sustained substrate for any functioning eNOS enzymes.
• Methylcobalamin & Magnesium: Vitamin B12 protects neural microvascular perfusion and homocysteine metabolism, while magnesium glycinate relaxes vascular smooth muscle via calcium channel modulation.

--------------------------------------------------------------------------------

CircO2 Dual-Pathway Vascular Matrix:

• Sodium Nitrite + Ascorbic Acid: Instant chemical reduction yielding active NO gas sublingually
• Standardized Beetroot: Substrate for oral microbiome symbiotic nitrate-to-nitrite reduction
• L-Citrulline: Renal conversion to pure L-arginine, sustaining baseline endothelial recycling
• Methylcobalamin & Magnesium: Neurovascular protection and smooth muscle calcium antagonism
• Form Factor: Nitrogen-flushed, individual aluminum blister cavities protecting against moisture

--------------------------------------------------------------------------------

The Vulnerability of Nitric Oxide Chemistry: Why Marketplaces Fail

Unlike stable vitamins or minerals, nitric oxide-generating nutraceuticals possess unique physicochemical vulnerabilities. The chemical efficacy of CircO2 depends on maintaining strict chemical latency until the moment the lozenge dissolves in the patient's saliva.

1. Hygroscopic Degradation and Atmospheric Oxidation

Sodium nitrite and ascorbic acid are highly hygroscopic compounds. If exposed to ambient relative humidity exceeding 45% or elevated temperatures:

• Ascorbic acid undergoes premature aqueous oxidation, turning brown and losing its electron-donating capacity.
• Premature acid-base reactions occur inside the bottle or blister pack, releasing volatile nitric oxide gas into the headspace of the container long before the consumer opens it.
• By the time the patient places the degraded tablet on their tongue, the active nitrite has transformed into inert, non-therapeutic nitrate salts.

2. The Necessity of Nitrogen-Flushed Aluminum Blister Packaging

To prevent premature atmospheric oxidation, the authentic manufacturer packages CircO2 in specialized high-barrier aluminum-aluminum blister foils flushed with inert nitrogen gas. Each lozenge is individually hermetically sealed in its own micro-environment, completely shielded from humidity, oxygen, and ultraviolet light.

Unauthorized counterfeit manufacturers, seeking to minimize production expenses, package their fake products in loose, non-barrier plastic bottles. Within days of storage in unmonitored e-commerce fulfillment warehouses, ambient heat and humidity degrade these unprotected counterfeit formulations into inactive chalk.

3. The Threat of Counterfeit Marketplace Lozenges

On unverified third-party platforms such as Amazon, eBay, and unapproved digital retailers, investigators have uncovered multiple classes of fraudulent CircO2 inventory:

1. Inert Sugar-Chalk Replicas: Counterfeiters compress sucrose, artificial coloring, and calcium carbonate to mimic the size and appearance of CircO2 lozenges. These replicas contain zero active nitrite and produce zero vascular response.
2. Expired, Degraded Liquidation Lots: Rogue liquidators acquire discarded, expired warehouse stock that has been subjected to severe temperature abuse, repackaging them with forged expiration dates.
3. Absence of Diagnostic Salivary Test Strips: Authentic CircO2 therapeutic packages include calibrated salivary nitric oxide test strips. Counterfeit packages either omit these diagnostic strips entirely or include non-calibrated, counterfeit strips that provide false-positive readings.

Forensic Physical Authentication Checklist: Authentic vs Counterfeit CircO2

Before administering CircO2 lozenges, patients must verify every packaging attribute using the following forensic authentication matrix:

If any blister pocket appears puffed, punctured, or discolored, the hermetic seal has been breached. Do not consume the lozenge; contact the official customer support portal for an immediate replacement.

Authorized Procurement Architecture and Therapeutic Pricing Structure

To maintain complete supply chain custody, prevent counterfeit infiltration, and guarantee that every blister pack arrives at peak chemical potency, Advanced Bionutritionals distributes authentic CircO2 exclusively through their official direct portal.

The manufacturer does not supply authentic CircO2 to brick-and-mortar health food retailers, independent pharmacies, or third-party e-commerce storefronts.

Genuine Direct-from-Manufacturer Pricing Tiers

When ordering through the authorized manufacturer website, patients can select from verified tiered packages designed to support systemic arterial remodeling:

• 1-Box Starter Supply (30 Lozenges / 30 Days): USD 49.95 per box plus standard shipping. Ideal for initial baseline salivary nitric oxide testing and tolerance evaluation.
• 3-Box Vascular Renewal Package (90 Lozenges / 90 Days): USD 44.95 per box (Total: USD 134.85) with free nationwide shipping. Recommended for establishing sustained microvascular perfusion and lowering systolic blood pressure trends.
• 6-Box Complete Arterial Compliance Package (180 Lozenges / 180 Days): USD 41.50 per box (Total: USD 249.00) with free nationwide shipping and complimentary diagnostic test strips. The optimal clinical package for reversing multi-year endothelial senescence, achieving permanent arterial flexibility, and maintaining continuous nitric oxide saturation.

The 90-Day 100% Money-Back Satisfaction Guarantee

Advanced Bionutritionals backs every authentic direct purchase with an unconditional 90-day 100% money-back guarantee. Patients are encouraged to test their salivary nitric oxide levels before starting CircO2, monitor their vascular response across three full months, and evaluate their physical energy.

If a patient is dissatisfied for any reason, they can return the used cartons and blister packs within 90 days of purchase for a prompt, full refund of the product purchase price. This guarantee applies strictly to orders placed directly through the official website.

Clinical Evidence Matrix: Verified Trials & Observational Data

The therapeutic efficacy of the enterosalivary nitric oxide pathway and sublingual lozenge delivery is validated by numerous peer-reviewed clinical investigations indexed in the National Library of Medicine (NCBI PubMed):

Narrative Synthesis of the Clinical Evidence

The kinetic investigation by Yamasaki & Nakao (PMID: 36838362) provides definitive biochemical validation for CircO2's core mechanism: when ascorbic acid interacts with inorganic nitrite in an aqueous oral environment, stoichiometric conversion to active nitric oxide gas occurs almost instantaneously.

Furthermore, the human clinical trials by Liddle et al. (PMID: 30528912) and Vanhatalo et al. (PMID: 29807159) demonstrate that elevating plasma nitrite through oral lozenge delivery produces clinically meaningful reductions in resting central blood pressure and robust improvements in flow-mediated dilation (FMD) in aging adults.

Crucially, Morou-Bermúdez et al. (PMID: 35081826) demonstrate that this pathway requires an intact oral microbiome. Patients must avoid chemical antiseptic mouthwashes, which destroy the oral commensal flora required to sustain the second phase of enterosalivary nitric oxide conversion.

Expected Clinical Response Timeline: 30, 60, and 90 Days

When authentic CircO2 is administered daily according to clinical sublingual guidelines, systemic vascular rejuvenation progresses through three distinct physiological phases:

Phase 1: Days 1 to 30 (Acute Endothelial Activation & Vasodilation)

Within 20 minutes of dissolving the initial lozenge, salivary test strips transition from pale white (depleted) to deep dark pink (optimal nitric oxide saturation):

• Systemic peripheral vascular resistance decreases, producing an average 5 to 10 mmHg reduction in resting systolic blood pressure.
• Cerebral blood flow increases, dispelling chronic brain fog and providing clean, non-stimulant mental clarity.
• Microvascular perfusion to extremities begins to improve, reducing feelings of cold hands and feet.

Phase 2: Days 31 to 60 (Microvascular Capillary Perfusion & Mitochondrial Oxygenation)

As daily nitric oxide bioavailability remains continuously saturated:

• Capillary bed density in peripheral skeletal muscle and myocardial tissue is functionally enhanced.
• Patients report noticeable increases in walking endurance, stair-climbing capacity, and cardiovascular stamina without shortness of breath.
• Nocturnal circulation improves, reducing nighttime leg cramps and promoting deeper restorative sleep.

Phase 3: Days 61 to 90 and Beyond (Structural Arterial Compliance & Endothelial Protection)

By the third month of uninterrupted enterosalivary therapy:

• Sustained nitric oxide signaling downregulates vascular cell adhesion molecules (VCAM-1 and ICAM-1), blunting vascular inflammatory cascades.
• Arterial walls regain physiological elastance, protecting against age-related pulse wave velocity acceleration.
• Cardiovascular risk profiles improve significantly, and patients maintain consistent, all-day vitality.

Practical Administration Protocol: Maximizing Sublingual Gas Absorption

To ensure maximum generation and transmucosal uptake of nitric oxide gas:

1. Administration Technique: Do NOT swallow the CircO2 lozenge whole with water. CircO2 is designed as an orally dissolving lozenge. Place the lozenge on your tongue or in the sublingual pocket beneath your tongue. Allow it to dissolve slowly over 2 to 3 minutes, moving it gently around your mouth.
2. Timing: Administer one lozenge once daily in the morning upon waking. Morning dosing counteracts the dangerous morning blood pressure surge, when myocardial infarction and ischemic stroke risks peak.
3. The Salivary Nitric Oxide Test: Use an included test strip before your first dose to establish baseline nitric oxide depletion. Test again 30 minutes post-dose to visually verify that the reactive pad turns deep pink, confirming active vascular absorption.
4. Strict Avoidance of Antiseptic Mouthwashes: Do NOT use chlorhexidine, alcohol-based, or strong antibacterial mouthwashes. Clinical research confirms that chemical mouthwashes eradicate oral nitrate-reducing bacteria on the tongue, destroying up to 90% of the body's enterosalivary nitric oxide production!
5. Hydration Guidance: Maintain adequate daily hydration. Nitric oxide enhances microvascular blood flow, which functions optimally when plasma volume is well maintained.

Contraindications, Drug Interactions, and Safety Boundaries

• Prescription PDE-5 Inhibitors: Patients taking prescription phosphodiesterase type-5 (PDE-5) inhibitors for erectile dysfunction or pulmonary hypertension (e.g., Sildenafil/Viagra, Tadalafil/Cialis, Vardenafil) must exercise extreme caution. Combining potent NO generators with PDE-5 inhibitors can cause profound, life-threatening hypotension. Consult your cardiologist prior to concurrent use.
• Organic Prescription Nitrates: Co-administration with prescription organic nitrates (e.g., Nitroglycerin, Isosorbide Mononitrate) is strictly contraindicated due to synergistic hypotensive risks.
• Severe Hypotension: Individuals with baseline resting systolic blood pressure below 90 mmHg should not use CircO2 without direct medical supervision.
• Pregnancy & Nursing: Contraindicated during pregnancy and lactation due to lack of comprehensive clinical safety data in these populations.

Frequently Asked Questions (FAQ)